ASX - By Stock
|
XRG |
Re:
Ann: $5.71 million State of Texas contract for Operator XR
|
|
Lucretious
|
23 |
4.3K |
7 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
23
|
4.3K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures $10m strategic investment from Pro Medicus
|
|
Lucretious
|
134 |
49K |
8 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
134
|
49K
|
8
|
|
ASX - By Stock
|
WRK |
Re:
Ann: Trading Halt
|
|
Lucretious
|
7 |
1.8K |
7 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
7
|
1.8K
|
7
|
|
ASX - By Stock
|
HMD |
Re:
Ann: HeraMED completes $1.98 million placement
|
|
Lucretious
|
1 |
396 |
2 |
06/08/25 |
06/08/25 |
ASX - By Stock
|
1
|
396
|
2
|
|
ASX - By Stock
|
CC5 |
Re:
Webinar 04/08/25
|
|
Lucretious
|
17 |
4.0K |
2 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
17
|
4.0K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lucretious
|
31 |
7.3K |
5 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
31
|
7.3K
|
5
|
|
ASX - By Stock
|
CDX |
Re:
Ann: June Quarterly Appendix 4C
|
|
Lucretious
|
22 |
5.6K |
10 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
22
|
5.6K
|
10
|
|
ASX - By Stock
|
WRK |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
Lucretious
|
4 |
1.5K |
4 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
4
|
1.5K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
RCE Chart Thread
|
|
Lucretious
|
54 |
12K |
5 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
54
|
12K
|
5
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 14 Jul 2025
|
|
Lucretious
|
37 |
11K |
4 |
17/07/25 |
17/07/25 |
ASX - Short Term Trading
|
37
|
11K
|
4
|
|
ASX - By Stock
|
GCM |
Re:
General Discussion - GCM
|
|
Lucretious
|
1.1K |
451K |
13 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
1.1K
|
451K
|
13
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Preliminary Approval for TPT Reimbursement Received
|
|
Lucretious
|
22 |
7.1K |
3 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
22
|
7.1K
|
3
|
|
ASX - By Stock
|
VMM |
Re:
Ann: VMM Targets U.S. Expansion with Rare Earth Refinery
|
|
Lucretious
|
73 |
22K |
5 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
73
|
22K
|
5
|
|
ASX - By Stock
|
VMM |
Re:
Ann: VMM Targets U.S. Expansion with Rare Earth Refinery
|
|
Lucretious
|
73 |
22K |
5 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
73
|
22K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Q4 FY25 sales and growth capital facility update
|
|
Lucretious
|
20 |
9.6K |
9 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
20
|
9.6K
|
9
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 14 Jul 2025
|
|
Lucretious
|
37 |
11K |
5 |
16/07/25 |
16/07/25 |
ASX - Short Term Trading
|
37
|
11K
|
5
|
|
ASX - By Stock
|
CPV |
Re:
Ann: Trial Shows ClearVue Solar Facade Delivers 2.6 Year Payback
|
|
Lucretious
|
74 |
22K |
13 |
16/07/25 |
16/07/25 |
ASX - By Stock
|
74
|
22K
|
13
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 14 Jul 2025
|
|
Lucretious
|
37 |
11K |
5 |
16/07/25 |
16/07/25 |
ASX - Short Term Trading
|
37
|
11K
|
5
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 14 Jul 2025
|
|
Lucretious
|
37 |
11K |
3 |
16/07/25 |
16/07/25 |
ASX - Short Term Trading
|
37
|
11K
|
3
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 14 Jul 2025
|
|
Lucretious
|
37 |
11K |
3 |
15/07/25 |
15/07/25 |
ASX - Short Term Trading
|
37
|
11K
|
3
|
|
ASX - By Stock
|
GCM Graphite |
Re:
GCM Chart
|
|
Lucretious
|
243 |
109K |
9 |
15/07/25 |
15/07/25 |
ASX - By Stock
|
243
|
109K
|
9
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 14 Jul 2025
|
|
Lucretious
|
37 |
11K |
5 |
14/07/25 |
14/07/25 |
ASX - Short Term Trading
|
37
|
11K
|
5
|
|
ASX - By Stock
|
CC5 |
Re:
Ann: Instrument Sale to Novo Nordisk for Group Evaluation
|
|
Lucretious
|
63 |
19K |
2 |
14/07/25 |
14/07/25 |
ASX - By Stock
|
63
|
19K
|
2
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 14 Jul 2025
|
|
Lucretious
|
37 |
11K |
3 |
14/07/25 |
14/07/25 |
ASX - Short Term Trading
|
37
|
11K
|
3
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 7 jul 2025
|
|
Lucretious
|
42 |
11K |
2 |
10/07/25 |
10/07/25 |
ASX - Short Term Trading
|
42
|
11K
|
2
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 7 jul 2025
|
|
Lucretious
|
42 |
11K |
4 |
10/07/25 |
10/07/25 |
ASX - Short Term Trading
|
42
|
11K
|
4
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 7 jul 2025
|
|
Lucretious
|
42 |
11K |
4 |
10/07/25 |
10/07/25 |
ASX - Short Term Trading
|
42
|
11K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Announces First US Remplir Sales Revenue
|
|
Lucretious
|
25 |
10K |
34 |
10/07/25 |
10/07/25 |
ASX - By Stock
|
25
|
10K
|
34
|
|
ASX - By Stock
|
PCK |
Re:
Ann: PainChek Reports Strong Quarterly Sales Growth
|
|
Lucretious
|
40 |
14K |
8 |
03/07/25 |
03/07/25 |
ASX - By Stock
|
40
|
14K
|
8
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Second Complete Response in ACCENT Pancreatic Cancer Trial
|
|
Lucretious
|
693 |
227K |
19 |
02/07/25 |
02/07/25 |
ASX - By Stock
|
693
|
227K
|
19
|
|
ASX - By Stock
|
HMD |
Re:
Technical Chart
|
|
Lucretious
|
4 |
1.8K |
0 |
01/07/25 |
01/07/25 |
ASX - By Stock
|
4
|
1.8K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Technical Chart
|
|
Lucretious
|
4 |
1.8K |
3 |
01/07/25 |
01/07/25 |
ASX - By Stock
|
4
|
1.8K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Second Complete Response in ACCENT Pancreatic Cancer Trial
|
|
Lucretious
|
693 |
227K |
10 |
27/06/25 |
27/06/25 |
ASX - By Stock
|
693
|
227K
|
10
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Lucretious
|
2.1K |
853K |
6 |
27/06/25 |
27/06/25 |
ASX - By Stock
|
2.1K
|
853K
|
6
|
|
ASX - By Stock
|
EDE |
Re:
Ann: Entitlement Offer, Security Consolidation and Loan Repayment
|
|
Lucretious
|
21 |
7.1K |
7 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
21
|
7.1K
|
7
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading June 20
|
|
Lucretious
|
112 |
28K |
0 |
20/06/25 |
20/06/25 |
ASX - Day Trading
|
112
|
28K
|
0
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 16 Jun 2025
|
|
Lucretious
|
31 |
9.2K |
3 |
20/06/25 |
20/06/25 |
ASX - Short Term Trading
|
31
|
9.2K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Signs Debt Facility with Avenue Capital Group
|
|
Lucretious
|
17 |
4.1K |
3 |
17/06/25 |
17/06/25 |
ASX - By Stock
|
17
|
4.1K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Ann: PainChek has productive final FDA De Novo clearance meeting
|
|
Lucretious
|
43 |
19K |
14 |
05/06/25 |
05/06/25 |
ASX - By Stock
|
43
|
19K
|
14
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Successful Placement of Entitlement Offer Shortfall
|
|
Lucretious
|
17 |
6.1K |
5 |
04/06/25 |
04/06/25 |
ASX - By Stock
|
17
|
6.1K
|
5
|
|
ASX - By Stock
|
EPM |
Re:
Ann: EPM Unveils 89mt Rare Earths Resource Increase at Gronnedal
|
|
Lucretious
|
93 |
35K |
8 |
03/06/25 |
03/06/25 |
ASX - By Stock
|
93
|
35K
|
8
|
|
ASX - By Stock
|
CC5 |
Re:
Ann: Pharmaceutical Market Update
|
|
Lucretious
|
51 |
21K |
1 |
30/05/25 |
30/05/25 |
ASX - By Stock
|
51
|
21K
|
1
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 26 May 2025
|
|
Lucretious
|
41 |
10K |
2 |
30/05/25 |
30/05/25 |
ASX - Short Term Trading
|
41
|
10K
|
2
|
|
ASX - By Stock
|
PCK |
Re:
PCK Chart
|
|
Lucretious
|
107 |
51K |
6 |
29/05/25 |
29/05/25 |
ASX - By Stock
|
107
|
51K
|
6
|
|
ASX - By Stock
|
PCK |
Re:
Ann: PainChek partners with Eldermark to expand US market reach
|
|
Lucretious
|
24 |
10K |
3 |
29/05/25 |
29/05/25 |
ASX - By Stock
|
24
|
10K
|
3
|
|
ASX - By Stock
|
EDE |
Re:
Ann: EdenCrete Product Sales Update
|
|
Lucretious
|
122 |
37K |
12 |
29/05/25 |
29/05/25 |
ASX - By Stock
|
122
|
37K
|
12
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Anything but Charting
|
|
Lucretious
|
35K |
16M |
2 |
28/05/25 |
28/05/25 |
ASX - By Stock
|
35K
|
16M
|
2
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Lucretious
|
2.1K |
853K |
17 |
27/05/25 |
27/05/25 |
ASX - By Stock
|
2.1K
|
853K
|
17
|
|
ASX - By Stock
|
EDE |
Re:
Ann: Sale of Georgia USA Property Update
|
|
Lucretious
|
16 |
5.8K |
7 |
27/05/25 |
27/05/25 |
ASX - By Stock
|
16
|
5.8K
|
7
|
|
ASX - By Stock
|
BLG |
Re:
Ann: BluGlass to host virtual Business Update webinar
|
|
Lucretious
|
5 |
3.0K |
11 |
27/05/25 |
27/05/25 |
ASX - By Stock
|
5
|
3.0K
|
11
|
|